Saving Lives at Birth

Author: Marya Lieberman

Postpartum hemorrhage (PPH) is responsible for 35% of maternal deaths worldwide, most in low and moderate income countries.  The leading medicine used to treat PPH and manage labor is injectable oxytocin.  But one in four women in Africa who are given this life-saving drug receive products that don't meet quality standards. The problem is that oxytocin must be refrigerated, but midwives and rural clinics often don't have access to reliable cold storage.  

Tracy-Lynn Cleary is developing a paper test card that can detect bad quality oxytocin in field settings.  Her proposed innovation has been selected as a finalist for a Saving Lives at Birth seed grant.  We will be attending the Saving Lives at Birth DevelopmentXChange 2017 meeting next week, hope to see some old friends there and meet new partners in the fight to ensure that all patients get access to the good quality medicine they need.  

Vote for your favorite innovations on the Saving Lives at Birth website and attend #DevX2017 on July 27th to see the latest in MNCH innovation: